Contact Us
Drug Search Results
More Filters [+]

Trafermin

Alternative Names: trafermin
Latest Update: 2023-05-24
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: FGFR Agonist

Novel Mechanism: No

Modality: Peptide/Protein

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Japan

Approved Indications: None

Known Adverse Events: None

Company: Kaken Pharmaceutical Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Trafermin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Periodontitis|Diabetic Foot|Alveolar Bone Loss|Periodontal Attachment Loss

Phase 2: Periodontitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
The TRAfermin in Neuropathic diabetic foot ulcer Study - southern Europe. The TRANS-North study

P3

Completed

Diabetic Foot

2013-02-06

The TRAfermin in Neuropathic diabetic foot ulcer Study - northern Europe. The TRANS-North study

P3

Terminated

Diabetic Foot

2012-09-30

TRANS-North

P3

Completed

Diabetic Foot

2012-05-01

TRANS-South

P3

Completed

Diabetic Foot

2012-03-01

Recent News Events

Date

Type

Title

05/24/2023

PubMed

 Lumbar Sympathetic Ganglion Block Facilitates Wound Healing in a Rat Ischemic Hindquarter Model.

05/02/2023

PubMed

 One Year Outcomes and Longitudinal Changes in Voice Improvement With Single High Dose Intracordal Trafermin Injections for Age-Related Vocal Fold Atrophy.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions